Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kejin Wu

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cancer Epidemiology|February 14, 2013
Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studiesYijun Jia, Yunshu Lu, Kejin Wu, et al.
Aging|November 13, 2019
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironmentFang Bai, Yuchun Jin, Peng Zhang, et al.
Molecular Cancer Therapeutics|January 17, 2014
Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugsSuyu Miao, Kejin Wu, Bo Zhang, et al.
Plos One|January 4, 2017
An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsQing Chen, Ziyi Weng, Yunshu Lu, et al.
Journal for Immunotherapy of Cancer|April 18, 2020
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancerFang Bai, Peng Zhang, Yipeng Fu, et al.
Plos One|September 23, 2024
Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsQing Chen, Ziyi Weng, Yunshu Lu, et al.
Journal of Oncology|May 4, 2022
Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast CancerMaoli Wang, Ruifa Feng, Zihao Chen, et al.
International Journal of Nanomedicine|March 23, 2018
Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancerFang Bai, You Yin, Ting Chen, et al.
Oncology Letters|January 27, 2017
Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubesYijun Jia, Ziyi Weng, Chuanying Wang, et al.
Biochemical and Biophysical Research Communications|October 29, 2017
Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancerYunshu Lu, Yipeng Yang, Yan Liu, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cancer Epidemiology|February 14, 2013
Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studiesYijun Jia, Yunshu Lu, Kejin Wu, et al.
Aging|November 13, 2019
Bioinformatic profiling of prognosis-related genes in the breast cancer immune microenvironmentFang Bai, Yuchun Jin, Peng Zhang, et al.
Molecular Cancer Therapeutics|January 17, 2014
Synuclein γ compromises spindle assembly checkpoint and renders resistance to antimicrotubule drugsSuyu Miao, Kejin Wu, Bo Zhang, et al.
Plos One|January 4, 2017
An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsQing Chen, Ziyi Weng, Yunshu Lu, et al.
Journal for Immunotherapy of Cancer|April 18, 2020
Targeting ANXA1 abrogates Treg-mediated immune suppression in triple-negative breast cancerFang Bai, Peng Zhang, Yipeng Fu, et al.
Plos One|September 23, 2024
Correction: An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor XenograftsQing Chen, Ziyi Weng, Yunshu Lu, et al.
Journal of Oncology|May 4, 2022
Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast CancerMaoli Wang, Ruifa Feng, Zihao Chen, et al.
International Journal of Nanomedicine|March 23, 2018
Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancerFang Bai, You Yin, Ting Chen, et al.
Oncology Letters|January 27, 2017
Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubesYijun Jia, Ziyi Weng, Chuanying Wang, et al.
Biochemical and Biophysical Research Communications|October 29, 2017
Upregulation of PAG1/Cbp contributes to adipose-derived mesenchymal stem cells promoted tumor progression and chemoresistance in breast cancerYunshu Lu, Yipeng Yang, Yan Liu, et al.
Pageof 5